SANOFI3,109.80

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹7,153 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation39.638.2
+ Finance Costs1.71.5
+ Interest Income-47.5-16.6
+ Share-based Payments6.11.2
+ Unrealised FX (Gain) / Loss-0.40.6
+ Other Non-cash Items-1.20.7
+ Other — Cash Effects are Investing / Financing-23.1-0.5
+ Other Reconciling Items0.0131.0
Changes in Working Capital
+ Inventories-255.868.7
+ Trade Receivables — Current0.6-127.0
+ Other Financial Assets — Current-0.7-35.7
+ Other Financial Assets — Non-current4.0-2.1
+ Other Current Assets10.0-89.8
+ Other Non-current Assets0.1-0.7
+ Trade Payables — Current-66.9166.2
+ Other Financial Liabilities — Current4.013.4
+ Other Current Liabilities-17.5-7.3
+ Provisions — Current-26.8-14.3
Cash from Operating Activities
Profit Before Tax (per I/S)864.3845.5431.4
+ Total Adjustments (incl. Working Capital)-373.8127.5
Cash from Operations (pre-tax)471.7558.9
+ Income Taxes Paid241.397.4
Cash from Operating Activities230.4461.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)34.336.4
+ Interest Received — Investing47.516.6
+ Other Inflows / (Outflows) — Investing24.30.6
Cash from Investing Activities37.5-19.2
Cash from Financing Activities
+ Payment of Lease Liabilities10.00.0
+ Payment of Finance Lease Liabilities0.07.8
+ Dividends Paid868.3384.6
+ Other Inflows / (Outflows) — Financing0.0-160.6
Cash from Financing Activities-878.3-553.0
Net Changes in Cash (pre-FX)-610.4-110.7
Net Changes in Cash-610.4-110.7
Closing Cash394.5283.8
Reference Items
EBITDA834.7803.7490.8
EBITDA Margin %30.1328.1924.38
Free Cash Flow (CFO − Capex)196.1425.1
Free Cash Flow to Equity425.1
Free Cash Flow per Basic Share85.26184.83
Cash Flow to Net Income0.381.12
Cash Paid for Taxes241.397.4
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.